These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6390867)

  • 21. Photopheresis therapy for problematic renal allograft rejection.
    Jardine MJ; Bhandari S; Wyburn KR; Misra AK; McKenzie PR; Eris JM
    J Clin Apher; 2009; 24(4):161-9. PubMed ID: 19536814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal allograft failure after simultaneous pancreas-kidney transplantation: univariate and multivariate analyses of donor and recipient risk factors.
    Douzdjian V; Rice JC; Carson RW; Gugliuzza KG; Fish JC
    Clin Transplant; 1996 Jun; 10(3):271-7. PubMed ID: 8826665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of prognostic factors affecting renal allograft survival.
    Xiao X; Li Y; Ao J; Chen Y
    Transplant Proc; 1992 Aug; 24(4):1442-6. PubMed ID: 1496611
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of renal allograft survival in the dog by passive administration of polyspecific antisera.
    Abouna GM; Barabas AZ; Vetters JM; Litchfied B
    Transplant Proc; 1979 Mar; 11(1):970-2. PubMed ID: 377732
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of donor and recipient age on renal allograft survival time.
    Cacciarelli TV; Sumrani N; Scriven R; DiBenedetto A; Hong JH; Sommer BG
    Transplant Proc; 1993 Dec; 25(6):3140-2. PubMed ID: 8266489
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequential study of immune mechanisms involved in graft acceptance in kidney transplantation.
    Mestre M; Bas J; Massip E; Valls A; Castelao AM; Grinyó JM; Alsina J; Buendia E
    Transplant Proc; 1995 Aug; 27(4):2371-3. PubMed ID: 7652843
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effect of Sandoglobulin upon allograft survival in the pediatric renal transplant recipient.
    Bunchman TE; Parekh RS; Kershaw DB; Smoyer WE; Flynn JT; Valentini RP; Sedman AB
    Clin Transplant; 1997 Dec; 11(6):604-7. PubMed ID: 9408693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy for rejection of renal transplant allografts refractory to medical immunosuppression.
    Wahl AO; Small W; Dixler I; Strom S; Rademaker A; Leventhal J; Abecassis MM
    Am J Clin Oncol; 2006 Dec; 29(6):551-4. PubMed ID: 17148990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
    Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
    Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model.
    Almond PS; Moss A; Nakhleh RE; Melin M; Chen S; Salazar A; Shirabe K; Matas AJ
    Transplantation; 1993 Aug; 56(2):275-81. PubMed ID: 8356580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early onset proteinuria after renal transplantation: a marker for allograft dysfunction.
    Ibis A; Altunoglu A; Akgül A; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2007 May; 39(4):938-40. PubMed ID: 17524856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of cytotoxicity against donor HLA markers by posttransplant sera from renal allograft recipients.
    Gülay Z; Bora S; Kavukçu S; Mehr MA; Elverdi B; Gülay H
    Transplant Proc; 1995 Oct; 27(5):2683-4. PubMed ID: 7482874
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of initial slow graft function on renal allograft rejection and survival.
    Humar A; Johnson EM; Payne WD; Wrenshall L; Sutherland DE; Najarian JS; Gillingham KJ; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):623-7. PubMed ID: 9408697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cold lymphocytotoxic antibodies (CLA) in human allograft recipients.
    Chalopin JM; Rifle G
    Transplant Proc; 1979 Jun; 11(2):1271-3. PubMed ID: 382506
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of nifedipine on renal allograft function and survival beyond one year.
    Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH
    Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.